Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.